96
Views
16
CrossRef citations to date
0
Altmetric
Perspectives

Point-of-care diagnostics – is this driven by supply or demand?

Pages 189-200 | Published online: 15 Mar 2010

Bibliography

  • Point of care diagnostics – players, products & future market prospects – Maddox J, espicom Business Intelligence; Conference; London; November 2009
  • Glorikian H. Market Trends & Dynamics in POCT, SMi Conference Point of Care Diagnostics – Adoption & Technology Trends, October 2009. SMi Conferences Ltd. London, UK; 2009
  • Huckle D. Changes in diagnostic practice. FT Pharmaceuticals & Healthcare Publishing; London; 1996
  • Huckle D. Point-of-Care diagnostics: an advancing sector with nontechnical issues, Expert Rev Mol Diagn 2008;8(6):679-88
  • Egan RL. Better and faster: improving rapid point-of-care testing. IVD Technol 2009;15(6):51-7
  • Price CP. Medical and economic outcomes of point of care testing. Clin Lab Med 2002;40:246-51
  • Blair E. Predictive tests & personalised medicine. Drug Discov World Fall 2009;10(4):27-8
  • Swanson J. Companion Diagnostics Take Off, Genome Technology Newsletter. Available from: www.genomeweb.com/print 924879 October 2009
  • Watwood D. Experiences in POC development and market uptake, SMi Conference Point of Care Diagnostics – Adoption & Technology Trends, October 2009. SMi Conferences Ltd. London, UK; 2009
  • Burnell S. The future of diagnostics: are labs vital?, Diagnostic report 2009, Cambridge Consultants Ltd. Cambridge, UK; 2009
  • Apple FS, Murakami MA, Christensen RH, Analytical performance of the i-stat cardiac troponin-I asay. Clin Chim Acta 2004;345:123-7
  • Hood L. Diagnostics get personal. IVD Technol 2009;15(6):24-33
  • Slatko J. When drugs get personal. MedAd News 2009;28(2):18
  • Little S. Business opportunities and commercial challenges in personalized medicine. IVD Technol 2008;14(3):35-40
  • Krul KP. Pitfalls undermine promise of theranostics. Genet Eng News 2008;28(16):16
  • Guiliano K, Grant ME. Blood analysis at the point of care: issues in application for critically ill patients. Point Care 2002;13(2):204-20
  • Fitzgibbon F, Brown A, Meenan BJ. Assessment of user perspectives of cardiac point of care technologies in chest pain diagnosis. Point Care 2008;7(2):1-7
  • Wong S. Promises & challenges of clinical genomics, opportunities & technology trends in global diagnostic testing markets. SMi Conference; London; June 2006
  • Edwards R. Pharmacodiagnostics: technologies, competition and market models, opportunities & technology trends in global diagnostic testing markets. SMi Conference; June 2006
  • Flanagen N. MDx hones in on near patient testing. Genet Eng News 2009;29(15):66-7
  • Price CP, Kricka LJ. Improving healthcare accessibility through point-of-care technologies. Clin Chem 2007;53:1665-75
  • The Science of personalised medicine: translating the promise into practice, pricewaterhouse Coopers report, November 2009 – see Genome Web Daily News; 8 December 2009
  • Kubitza L. The growth of personalised medicine will drive alliances between diagnostic and pharmaceutical industries. Drug Discov World Fall 2009:17-24
  • Dunlop L. Personalized medicine grows in fits & starts. Genet Eng News 2009;29(5):60-2
  • Guidance for Industry, Clinical Laboratories & FDA staff on in vitro diagnostic multi-variate index assays, FDA (USA) Draft in 2007 and final version; 2009
  • James A. POC diagnostics in improving health services, SMi Conference Point of Care Diagnostics – Adoption & Technology Trends, October 2009. SMi Conferences Ltd. London, UK; 2009
  • Thomas M, Mallet S, Nair D. A fully integrated approach to POCT, SMi Conference Point of Care Diagnostics – Adoption & Technology Trends, October 2009. SMi Conferences Ltd. London, UK; 2009
  • Pearson J. Establishing the clinical utility of POCT, Market Access for Point-of-Care Diagnostics, Conference Amsterdam May 2004. Available from: http://www.informa-is.com/POCT/docs
  • Point of Care Diagnostics 2010: rapid testing at a Cross Roads, Kalorama Information (Market Research Group LLC); November 2009
  • Reder A. Regulating the point of care: the IVD Connectivity industry consortium. Med Device Diagn Ind 2001;23(4):63-73
  • Mastrantonio F. Patient pathways and connectivity, SMi Conference Point of Care Diagnostics – Adoption & Technology Trends, October 2009. SMi Conferences Ltd. London, UK; 2009
  • Pearson J. Point-of-care testing and clinical governance. Clin Chem Lab Med 2006;44(6):765-7
  • van KM. New technology opens the door for change for the IVD Industry, Philips Electroinics, press release; 2008
  • Qiagen Press Release, 22 September 2009
  • Smiths Detection wins NIH grant for Flu diagnostics, Smiths Press release as noted GenomeWeb Daily News, 22 September 2009
  • Huckle D. Point-of-care diagnostics: will the hurdles be overcome this time? Expert Rev Med Devices 2006;3(4):421-6
  • Advances & Emerging Trends in Diabetes Monitoring, Technology Overview, Frost & Sullivan, 31 March 2008
  • Minimally non invasive glucose monitor real, start-up preview, Windhover Information, Inc. USA; December 2007
  • Nichols JH. Point of care testing. Chapter 50. In immunoassay handbook. 2nd edition. Nature Publishing Group, published; New York, USA; 2005
  • Harris SB, Webster-Bogart S, Porter S, Point-of-care testing in diabetes management: what role does it play? Diabetes Spect 2004;17:244-8
  • Hamilton AJ, Swales LA, Neill J, Risk stratification of chest pain patients in the emergency department by a nurse utilizing a point of care protocol. Eur J Emerg Med 2008;15:9-15
  • McGee P. Mass spectroscopy evolution drives discovery. Drug Discov Devel 2005. Editorial, May 18, 2005
  • Price CP, Kricka LJ. Point-of-Care testing: systems reengineering of healthcare provision to reduce errors and improve outcomes. Available from: www.bloodgas.org 2007
  • Fitzgibbon F, Brown A, Meenan BJ. Assessment of user perspectives of cardiac point of care technologies in chest pain diagnosis. Point Care 2008;7(2):1-7
  • Gardiner C, Williams K, Mackie IJ, Patient self-testing is a reliable and acceptable alternative to laboratory INR monitoring. Br J Haematol 2004;128:241-7
  • Petersen M. Economic Costs of Diabetes in the US in 2007. Diabetes Care 2008;31:596-615
  • Fox JK, Tran NK. Point of care testing and cardiac biomarkers: the standard of care and vision for chest pain centres. Cardiol Clin 2005;23:467-90
  • Hamilton AJ, Swales LA, Neill L, Risk stratification of chest pain patients in the emergency department by a nurse utilizing a point of care protocol. Eur J Emerg Med 2008;15:9-15
  • Hojvat S. FDA, Regulatory affairs and compliance in the USA, SMi Conference Point of Care Diagnostics – Adoption & Technology Trends, October 2009. SMi Conferences Ltd. London, UK; 2009
  • Point of care diagnostics: requirements from a notified body, Informa conference on Market Access for point of care diagnostics; June 2009
  • Diagnostic laboratories could be overwhelmed with Swine flu tests, lab medica news; October 2009
  • Nougairede A, Ninove L, Zandotti C, New accurate diagnostic test for swine H1N1 influenza using RT-PCR technology, Vector Borne and Zoonotic Diseases, Pre-publication release; June 2009
  • Centre for evidence based purchasing, NHS purchasing and supply agency (PASA) Evaluation report. Three point of care devices for troponin measurement [PASA Web site]. May 2006. Available from: http://www.pasa.nhs.uk/pasa/Doc.aspx?Path=[MN][SP]/NHSprocurement/CEP/poc/Report%2006020.pdf
  • Charny M. Reimbursement for Point-of-Care diagnostics Opportunities and Barriers. Market Access for Point-of-Care Diagnostics Conference, Amsterdam 13 – 14 May 2008. Available from: http://www.informa-ls.com/ POCT/docs
  • Price CP, Christenson RH, editors, Evidence-based laboratory medicine: principles, practice and outcomes. 2nd edition. AACC Press, Washington; 2007
  • Johal SS, Oliver P, Williams HC. Better decision making for evaluating new medical device projects – a real options approach. J Med Market 2008;8(2):101-12
  • George I. POC testing predicted to transform healthcare: bolster of evidence based standards. Genet Eng News 2009;29(8):54-6
  • Beware Buying Diagnostic Tests from the internet. Available from: www.centre4debtmanagement.com
  • Rajun A, Glorikian H. Point-of-care diagnostics: market trends and growth drivers. Expert Opin Med Diagn 2009;3(1):1-4
  • The Emerging European Molecular POC Testing Markets, Frost & Sullivan Communications, Market Research Report; April 2008
  • Shepherd M, Shepherd A, Watkinson L, Design, implementation and results of the quality control program for the Australian government's point of care testing in general practice trial. Ann Clin Biochem 2009;46:413-9
  • Pauly D, Kirchner S, Stoermann B, Simultaneous Quantification of five bacterial and plant toxins from complex matrices. Analyst 2009;134:2028-29
  • Leavitt M. Personalized health care: pioneers, partnerships, progress, US Dept of Health & Human Services; November 2008
  • Price CP, Kricka LJ. Point-of-care testing: systems reengineering of healthcare provision to reduce errors and improve outcomes. Available from: www.bloodgas.org 2007
  • Christel MD. R&D Spending will grow as industry pressures continue. MedAd News 2008;27(1):1

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.